A Study of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60 to 85 Years in Stable Health

NCT03819049 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

836

Enrollment

INDUSTRY

Sponsor class

Conditions

Extraintestinal Pathogenic Escherichia Coli Prevention

Interventions

BIOLOGICAL: ExPEC10V
BIOLOGICAL: ExPEC4V
BIOLOGICAL: Prevnar 13
BIOLOGICAL: Placebo

Sponsor

Janssen Research & Development, LLC